However, Rip3 deficiency exacerbates liver steatosis, apoptosis, adipose tissue inflammation, insulin resistance, and glucose intolerance induced by a HFD (Gautheron et al, 2016; Roychowdhury et al, 2016). Here, RIPK3 is linked to Glucose intolerance.